Category
38 plain-language articles on women's hormonal health — the physiology, the compounds, and what the evidence actually shows.
38 articles
Why your cycle gets worse during stressful seasons
During the easy seasons, your cycle is mostly cooperative. Mild PMS, predictable timing, manageable flow. Then a stressful stretch hits — a job change, a family situation, a sustained period of overwork — and the cycle starts behaving differently. PMS gets harder. The luteal phase becomes treacherous. Periods get heavier or longer, or skip altogether. Ovulation pain shows up. By the time things calm down, the cycle has rewritten itself.
Endometriosis and the inflammation cycle
Endometriosis is a structural disease. Ectopic endometrial-like tissue grows where it doesn't belong — on the ovaries, the peritoneum, the bowel, occasionally further afield — and it responds to the cyclical hormonal signals that drive the uterine lining. The lesions bleed, scar, and adhere. The pain is organic. The management is surgical and medical, and that has to be said clearly before anything else.
The four shifts of perimenopause — and which ones are driven by stress
Perimenopause is often described as a single transition, but the lived experience is more like four overlapping shifts happening at once — each with its own mechanism and its own timeline. Sleep changes, mood changes, cycle changes, hot flashes, energy collapse, weight redistribution, brain fog. They don't all share the same driver, which is why a single intervention rarely addresses all of them and why women describe perimenopause as feeling like several different transitions stacked on top of each other.
PMDD and the cortisol-progesterone connection
PMDD is not bad PMS. It's a distinct, diagnosable condition where the luteal phase doesn't just feel uncomfortable — it becomes destabilizing. Mood collapses. Rage arrives without warning. Suicidal ideation can show up in women who feel completely well three days later, after the period starts. The pattern repeats month after month, and the recognition that the timeline is hormonal does nothing to soften the experience of living through it.
Uterine fibroids and the stress factor
Fibroids are extraordinarily common — by age 50, the majority of women have at least one — and they range from incidental findings on a routine ultrasound to lesions that drive heavy bleeding, anemia, and pressure symptoms that meaningfully interfere with daily life. The conversation about fibroids and stress isn't whether stress causes them; it's whether the hormonal and inflammatory environment that influences their growth velocity is partly shaped upstream. The honest answer is yes — within limits worth being precise about.
Cetrorelix in IVF — what GnRH antagonism actually controls
You're on day eight of stimulation. You've been injecting FSH every morning, watching follicles grow on the ultrasound monitor, doing the math on retrieval timing with your reproductive endocrinologist. Everything is on schedule. Then you get a call from the clinic: your LH is starting to move. The nurse's voice is calm but there's urgency underneath it — because a premature LH surge at this point, before the eggs are mature, means the follicles might ovulate on their own before retrieval can happen. It means the cycle could be compromised. It means weeks of preparation and thousands of dollars might not yield the retrieval you were planning on. This is the clinical problem that Cetrorelix was designed to solve, and it solves it by going directly to the source.
Cetrorelix in IVF — the patient experience explained
You've been doing the stimulation injections for a week. Every morning you pull the Gonal-F or Follistim out of the refrigerator, you've gotten comfortable with the needle, and the monitoring appointments have confirmed the follicles are growing. Then the clinic calls: start the cetrorelix tomorrow. You look at the package in your refrigerator — a small pre-filled syringe, different from what you've been using — and you want to understand what it is and what it's doing before you inject it.
Curcumin and the NF-kB switch in endometriosis
Inside an endometriotic stromal cell, a great deal of bad behavior funnels through a single switch. Inflammatory signals arrive, oxidative stress builds, prostaglandins accumulate — and all of it converges on a transcription factor called NF-kB, which, once released, walks into the nucleus and turns on the genes that keep the lesion inflamed, fed, and invasive. Now picture a yellow pigment from a kitchen spice slipping into that same cell and jamming the switch one step upstream. That is, in essence, what curcumin does, and it is why a compound most people associate with curry has earned a place in the serious conversation about endometriosis biology.
ENDO-205 — the first peptide designed to remove endometriosis lesions, not just quiet them
For decades the menu for endometriosis has had two items on it, and both leave the disease itself largely in place. A surgeon can excise the visible implants, and a clinician can lower estrogen — with a pill, a progestin, a GnRH analogue, or a levonorgestrel IUD — to quiet the bleeding and the pain. Neither switches off the biology that regrows the lesions, which is why recurrence is common and why so many women cycle through repeat surgeries and a rotating cast of hormonal regimens that manage symptoms without resolving the thing producing them. The lesion is treated as tissue to cut out or as estrogen to suppress. It is rarely treated as a target in its own right.
The aromatase loop — how an endometriosis lesion makes its own estrogen
Take a thin section of normal uterine lining and stain it for aromatase, the enzyme that builds estrogen, and you find almost nothing — the eutopic endometrium expresses negligible amounts of it, drawing the estrogen it responds to from the ovary upstream. Now take a section of an endometriotic lesion from the peritoneum and run the same stain, and the picture inverts. The ectopic stroma lights up. It is transcribing CYP19A1, the gene for aromatase, in tissue that has no business making its own estrogen at all. That single difference — a lesion that has switched on a steroidogenic program the normal lining keeps off — is the root of why endometriosis behaves the way it does, and why the obvious strategy of starving it of ovarian estrogen so often falls short.
The endometriosis numbers worth tracking — and what they can and can't tell you
The lab printout arrives and almost everything sits inside the reference range, which is supposed to be reassuring and somehow isn't. The estradiol is a number. The progesterone is a number. There is a CRP value and a fasting insulin and, if the panel was thorough, a homocysteine and an SHBG buried near the bottom. Each one is flagged green, within limits, unremarkable. And yet the disease is unmistakably active — the pain tracks the cycle, the bloating is real, the days are still being lost. The gap between a panel that looks fine and a body that doesn't is where this conversation lives, and the first thing to say about it is also the most important: the numbers below are not a way to diagnose endometriosis, and the ranges attached to them are not diagnostic cut-offs. They are a way to watch biology move.
Endometriosis — what's actually happening at the lesion level
The pain starts before the bleed. Sometimes days before. It is not the ordinary ache of cramping — it is deeper, more insistent, occasionally radiating into the lower back and down the legs, occasionally involving the bowel in ways that are disorienting to connect to a reproductive condition. During sex there is pain in certain positions that isn't discomfort from pressure but something sharper, something that makes you hold very still, that you learn to predict and work around and eventually stop mentioning because the explanation takes longer than the conversation usually lasts. Sometimes the pain isn't cyclical at all — it is there on a Tuesday in the third week of the cycle for reasons that don't follow the pattern you've been told to expect. The period when it comes is heavy. The days you spend managing it are expensive in ways that compound: the workdays altered, the social commitments that don't happen, the quiet recalibration of what you can plan around and what you can't.
Scar tissue, macrophages, and endometriosis pain — and why the fibrosis may not be permanent
When a macrophage arrives at an endometriotic lesion, it has a choice of identities. In healthy tissue these large immune cells are the body's clean-up crew: they engulf debris, clear dying cells, and resolve inflammation once a threat has passed. But in the peritoneal cavity of someone with endometriosis, the macrophage is recruited by a chemical signal called CCL2 and then held in place by another, CSF-1, and under that local instruction it adopts a different phenotype altogether. It becomes alternatively activated — M2-like — which sounds technical and is, in fact, the crux of the disease. An M2-like macrophage is permissive rather than clearing. It does not remove the ectopic tissue. It tolerates it, and worse, it feeds it.
Insulin, body fat, and endometriosis — the fuel the lesion runs on
An endometriotic cell, transplanted onto the peritoneum where it does not belong, faces an immediate problem: the ectopic niche is hypoxic, low on oxygen, and a normal cell would struggle to make enough energy there to survive. The lesion's cells solve this the way many aggressive tissues do, by shifting their metabolism toward glycolysis — burning glucose rapidly in the cytoplasm rather than relying on oxygen-dependent mitochondrial respiration. This is a Warburg-like phenotype, the same metabolic signature seen in tumors, and it is not a malfunction so much as an adaptation. It favors survival and proliferation precisely where conditions are hostile. The lesion has, in effect, rewired its fuel economy to thrive in a place it should not be able to live.
Why one drug rarely controls endometriosis — the multi-nodal idea
You have probably been handed one lever at a time. A combined contraceptive, then a progestin when that wasn't enough, then a GnRH analogue when that wasn't enough either, each one introduced as the thing that should finally settle the disease, each one helping for a while and then quietly underdelivering. The pattern is so common that it can start to feel like a personal failure to respond — as if your body were uniquely stubborn. It isn't. The pattern is what you would predict if you understood what the lesion is actually built from, because the disappointing arithmetic of one-drug-at-a-time falls directly out of the biology.
NF-κB — the master inflammation switch inside an endometriosis lesion
Inside an endometriotic lesion sits a protein complex that the cell normally keeps under lock and key. It is called nuclear factor kappa B — NF-κB — and in its resting state it is tethered in the cytoplasm by an inhibitor, IκBα, that physically blocks it from reaching the nucleus. Then a signal arrives: a cytokine docks at a surface receptor, oxidative stress builds, a prostaglandin floods the local tissue. A kinase named IKKβ phosphorylates IκBα, marking it for degradation, and the inhibitor is destroyed. Freed, the canonical NF-κB dimer — the p65/p50 pairing — translocates into the nucleus and begins to read off genes. Within minutes, the lesion has reprogrammed itself toward inflammation.
Why endometriosis comes back after surgery — the biology excision doesn't touch
The surgery was supposed to be the end of it. You did everything right — you found a surgeon who excised rather than ablated, you got the histology back confirming what you already knew, you had months where the pain genuinely lifted, and you had a levonorgestrel IUD placed afterward that quieted the bleeding to almost nothing. For a while it felt like you had crossed to the other side of the disease. And then, somewhere past the first year and well before the fifth, the old ache returned — the deep, pre-menstrual pull that you recognized instantly, the pain with sex in the same positions, the bowel symptoms tracking back to your cycle even though the cycle itself had gone quiet. You went back, and you were told the surgery had been successful, which it had been, and that the IUD was working, which it also was, and somehow both of those things were true while the disease was clearly back.
GLP-1s and endometriosis — the metabolic lever and the early signal
She started the medication for her weight, or for her blood sugar, or because her own clinician had run out of other ideas for the insulin resistance that had shadowed her for a decade. The pelvic pain was not the reason. And then, somewhere in the second or third month, she noticed that the bloating that had become a fixed feature of her body had eased, that the low-back ache she had stopped mentioning was quieter, that the days she lost to pain had become fewer. She had not expected any of that. Nobody had promised it. The drug was doing something to a part of her biology that, it turned out, her endometriosis had been quietly drawing on the whole time.
GLP-1s in perimenopause — when nothing else is working
You are eating the way you ate at thirty-five. You're training four days a week, sometimes five. You sleep reasonably well, you don't drink much, you track your food on and off and it's not dramatic. And the weight is still going in the wrong direction, or it isn't moving at all, or it's moving to your abdomen and waist in a way it never did before and no amount of core work touches it. You've been told it's stress. You've been told it's perimenopause and to just wait it out. You've been told your labs are normal. And you're standing in a body that feels like it's operating on entirely different rules than the one you've lived in for the last two decades.
IVF recovery — the inflammation conversation after the protocol ends
The retrieval was on a Tuesday. By Thursday you were back in your apartment, moving carefully, eating saltines, bloated in a way that felt less like digestion and more like your abdomen had been rearranged. Which, in a way, it had. The nurses said the discomfort was normal, that it would pass. And it did pass — the acute part. What nobody prepared you for was the month that followed: the fatigue that didn't lift, the anxiety that arrived from nowhere, the skin flare you hadn't had since your twenties, the feeling that your body was running a background process it hadn't told you about.
Hot flashes and night sweats — what's actually happening at the hypothalamic level
The wave starts at the chest. Not pain, not quite — more like a pressure that turns into heat, spreading upward through the sternum and into the face before you have time to name what's happening. Your skin blooms red. The back of your neck dampens. You push the covers off and in four minutes it's over, leaving you cooled and clammy and awake at 2:47 in the morning. Then again at 4:11. During the day it arrives without warning in the middle of a sentence, and you pause, not because you've forgotten what you were saying, but because you are suddenly on fire and that seems like it should matter more than whatever you were saying. This is the vasomotor symptom — the hot flash, the night sweat, the thermoregulatory system misfiring in ways that disrupt sleep, concentration, work, and quality of life in patterns that are exhausting in proportion to how invisible they are to everyone around you.
N-acetylcysteine for endometriosis — the strongest non-hormonal signal
In a small Italian clinic, a group of women with ovarian endometriomas were given a simple, decades-old over-the-counter compound and asked to come back for repeat imaging. When they did, something quietly unusual showed up on the scans: a number of the cysts had not grown the way endometriomas usually do between visits, and several had shrunk. In the women who took nothing, the cysts continued along their expected trajectory. The compound was not a hormone. It was not a surgical instrument. It was N-acetylcysteine — a cysteine donor that pharmacists have stocked for years as a mucolytic and as the antidote for acetaminophen overdose. That a substance this unglamorous produced a measurable, lesion-level change in a disease defined by its stubbornness is the reason it deserves a careful look.
PCOS — the metabolic-reproductive condition and the peptide conversation
Your cycles have never been regular. Or they were, and then they weren't. Your skin produces oil faster than you can manage it; there are cysts along your jawline that come back in the same places regardless of what you use. There is hair growing where you don't want it — along the chin, the sideburns, sometimes the abdomen — and hair thinning where you do. Your weight doesn't behave the way effort should predict: you eat carefully, you exercise, and the number on the scale moves reluctantly or not at all, while visceral fat distributes itself around your waist in a pattern that feels metabolic rather than dietary. When you mention any of this in a clinical context, you are sometimes told you have PCOS; sometimes you are told you might; sometimes you are told to lose weight, as though that were the first step rather than a symptom of the same underlying dysregulation that's driving everything else. The diagnosis, when it arrives, often arrives late — sometimes years after the symptoms began, sometimes only when fertility becomes the immediate concern.
The peptides being explored for endometriosis — and what's actually known
By the time many women reach the peptide conversation, they have already done the expected things. They have had the laparoscopy, perhaps more than one. They are on a progestin or carry a levonorgestrel IUD that controls the bleeding without quieting the deeper ache. And somewhere along the way they have found the forums and the clinics where peptides are discussed with a confidence the published evidence does not yet support — KPV for inflammation, BPC-157 for repair, a stack of injectables with names that sound like the future. The pull is understandable. The honest answer is more complicated, and worth laying out carefully, because the gap between what these molecules might do and what is actually known about them in endometriosis is where people get hurt.
Peptides for postmenopause — what changes when the transition is complete
You expected it to feel like an ending. What you didn't expect was that it would feel like a new set of problems you hadn't been warned about. The hot flashes are mostly gone. The sleep is better than it was during the worst of the transition. But the body doesn't feel like your body. There's weight sitting around your middle that wasn't there before and that doesn't respond to the things that used to work. Your joints are stiffer in the morning. The skin looks different in a way that isn't just about sun damage. And somewhere in the back of your mind is a number your doctor mentioned at your last visit — your DEXA score, slightly lower than it was three years ago — and the arithmetic of that number over the next two decades is not entirely comfortable to sit with.
Peptides for perimenopause — across the four shifts that happen at once
You wake up at 3 a.m. soaked in sweat, heart thumping, and by the time you kick the covers off you're cold. An hour later you're awake again, this time for no reason you can name — just alert, mind moving, the familiar tired-but-wired feeling you've been carrying for months. Your cycle has been irregular for about a year. Some months it's fine. Other months you skip entirely, or it arrives weeks early and harder than it used to. You mentioned the sleep to your doctor and she said your labs were normal. Estrogen looked fine, she said. Maybe stress.
Peptides for the postpartum recovery arc — what research has explored after breastfeeding ends
Nobody tells you that the six-week checkup is mostly a box-checking exercise and that the actual recovery arc is measured in years. You show up, you answer questions about mood and bleeding and whether you're sleeping, and you leave with clearance to exercise and resume sex and get on with things. What the appointment doesn't address is the hair that started falling out at three months. The body composition that reorganized itself in ways that don't resolve with the same effort they once would have. The energy that never fully returned to baseline. The sleep that, even after the infant started sleeping through the night, remained fractured and unrestorative in a way that felt structural. You are technically recovered by the metrics medicine uses. You do not feel recovered in the ways that matter.
Peptides and pregnancy preparation — what to discontinue, what may help preconception
You've been building a wellness protocol for a while — maybe a GLP-1 agonist, maybe a peptide or two, maybe a stack of supplements that took months to refine. And then comes the conversation where you decide you want to try to conceive. And suddenly the question is not what to add. The question is what to stop, when to stop it, and what the three to six months before trying actually requires of you biologically.
Peptides for vaginal and genitourinary health — the GSM conversation
You mentioned it at the appointment because something finally made you say it out loud. The dryness. The discomfort during sex that had changed from occasional to reliable. The urgency that sends you to the bathroom three times before you can leave the house. Maybe the infections, arriving again and again for the first time in years. Your provider nodded, wrote something, said this is very common. Handed you a pamphlet. Moved on.
Perimenopause — what's changing across multiple systems at once
Your cycles have started to change. Not dramatically — maybe just a day or two shorter than usual, or occasionally longer, or one that arrived early and light and felt different in character. You are sleeping differently: you fall asleep fine and wake at three or four in the morning with a restless alertness that didn't used to be there, and when you do sleep you feel like you're not going deep enough. The weight around your middle is new. It appeared without a corresponding change in diet or exercise and it doesn't respond the way weight used to respond. Your mood has an edge to it — not depression exactly, more like a reduced buffer between the ordinary irritations of the day and your nervous system's reaction to them. Your skin feels different. Your hair, maybe. Your desire for sex, possibly. And you are forty-three, or forty-one, or forty-seven, and no one has said the word perimenopause to you.
PMS and PMDD — the cyclical symptom pattern that gets dismissed
You know the date by how you feel before you look at the calendar. Around day twenty-one your stomach starts to bloat, your bra fits differently, there is a low-level tenderness across your chest that makes you change how you sleep. Cravings arrive with a kind of insistence that doesn't feel like hunger — it feels driven, almost compelled, the body demanding something specific. And then the mood. Not sadness exactly, not always. Sometimes it's an irritability that appears out of proportion to its triggers — a small thing that becomes enormous, a patience that runs out much faster than it should. Sometimes it's a withdrawal, a heaviness, a sense of dread that visits each month with predictable timing and lifts, almost immediately, when the period begins. You feel it reset. And then two weeks later, you feel it starting again.
Coming off birth control — the cycle that doesn't quite return
You stopped the pill on a Sunday. Your doctor said your cycle would return in a few weeks. Maybe a month. By month three, you had a period — one period — and then silence for another eight weeks. The acne that started showing up on your jaw looked exactly like what you had at seventeen. Your skin was oily in a way it hadn't been in years. Your hair felt different. You felt different, in a way that's hard to articulate but impossible to ignore — more reactive, more raw, cycling through moods in ways you didn't remember doing before. The pill, you realized, had been doing more than preventing pregnancy.
Postpartum recovery — the year-long hormonal story
You made it to your six-week checkup. The provider glanced at your incision or asked about bleeding, confirmed you were cleared for exercise and sex, and sent you home. Maybe you were still bleeding. Maybe you hadn't slept more than two consecutive hours since the birth. Maybe you cried in the car on the way there for reasons you couldn't fully explain. The appointment took eleven minutes.
Preconception and peptides — what to discontinue before trying to conceive
You've been on a peptide protocol for six months. The body composition is better, sleep is better, the metabolic markers have moved in the right direction. And now you and your partner are talking seriously about timing — the conversation is shifting from optimization to readiness, and your reproductive endocrinologist has started discussing the actual conception window. You want to do this thoughtfully. You're not sure which of what you're taking needs to stop before you start trying, and nobody in your care team has given you a clear answer.
Feeling pregnant when you're not — the mid-cycle and perimenopausal phantom pregnancy
You're not pregnant. You know this with certainty — you've taken the test, you have your reasons for certainty, you're not in a life stage where it's plausible. And yet. Your breasts are tender enough that a hug is uncomfortable. You're faintly nauseated after eating, the kind that doesn't quite resolve and isn't quite bad enough to do anything about. You're more tired than usual in a way that doesn't connect to sleep. You're bloated. And if you've been pregnant before, there is a particular and uncanny quality to the familiarity of it — you recognize this feeling from somewhere. You recognize it from those first weeks.
The perimenopausal athlete — when training stops responding the way it did
You've been doing this for fifteen years. You know your body. You know what a hard week feels like versus overtraining, what a legitimate recovery day is versus avoidance, what it means when your legs are heavy versus genuinely depleted. You've run the marathon. You've hit the lifts. You've done the discipline that most people say they don't have time for, and you actually have. And then something changed. Not dramatically, not overnight, but over eighteen months or two years, something in the system stopped responding the way it was supposed to. The training that used to drive adaptation is now producing fatigue that doesn't resolve. The recovery that used to take a day is now taking three. The body composition is drifting despite the same protocol that held it stable for years. You've taken recovery weeks, tried periodization adjustments, gone back to basics. The sports medicine provider said "overtraining" and told you to rest. You rested. It didn't fix it. And you're starting to wonder if the problem isn't the training.
Vitamin D and omega-3 in endometriosis — the quiet anti-inflammatory levers
Pull the lab panel of a roomful of women with endometriosis and a pattern keeps surfacing: the 25-hydroxyvitamin D values run low, and the lowest of them cluster in the women whose disease is most advanced. It is the kind of association that is easy to dismiss as background noise — vitamin D is low in a great many conditions — until you look at what the vitamin actually does inside the tissues that endometriosis colonizes. Then the correlation starts to look less like coincidence and more like a clue. Vitamin D and the omega-3 fatty acids in fish oil are the two quietest levers in the endometriosis conversation, unglamorous next to surgery and hormones, and both turn out to act on the disease's biology in ways that are well understood at the molecular level even where the clinical proof is still arriving.
Women on HRT — integrating peptide considerations with hormone therapy
You switched to transdermal estradiol eight months ago and the difference was real. The hot flashes stopped. Sleep improved. The brain fog that had been making you feel like a stranger in your own thinking lifted enough that you remember what it felt like to be sharp. Oral progesterone at night deepened sleep in a way you hadn't had in years. HRT did what it was supposed to do. And yet you're still navigating things it didn't fix — the body composition that keeps shifting toward the middle despite unchanged eating habits, the recovery from exercise that feels slower than it should, the joints that ache in a way they didn't at forty. You're reading about peptides and wondering what the relationship is between what you're already taking and what might be added.